Hurdles in bacteriophage therapy: Deconstructing the parameters
- 1 July 2014
- journal article
- review article
- Published by Elsevier in Veterinary Microbiology
- Vol. 171 (3-4) , 460-469
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- T4 Phage and Its Head Surface Proteins Do Not Stimulate Inflammatory Mediator ProductionPLOS ONE, 2013
- Significance of the Bacteriophage Treatment Schedule in Reducing Salmonella Colonization of PoultryApplied and Environmental Microbiology, 2012
- Spontaneous and transient defence against bacteriophage by phase‐variable glucosylation of O‐antigen in Salmonella enterica serovar TyphimuriumMolecular Microbiology, 2012
- Identification of Avian Pathogenic Escherichia coli Genes That Are Induced In Vivo during Infection in ChickensApplied and Environmental Microbiology, 2012
- Pros and cons of phage therapyBacteriophage, 2011
- Efficacy of Bacteriophage Therapy in a Model ofBurkholderia cenocepaciaPulmonary InfectionThe Journal of Infectious Diseases, 2010
- Quantitative Models of In Vitro Bacteriophage–Host Dynamics and Their Application to Phage TherapyPLOS Pathogens, 2009
- Experimental Phage Therapy against Staphylococcus aureus in MiceAntimicrobial Agents and Chemotherapy, 2007
- Models of phage growth and their applicability to phage therapyJournal of Theoretical Biology, 2004
- Understanding Bacteriophage Therapy as a Density-dependent Kinetic ProcessJournal of Theoretical Biology, 2001